Search Results - "Loustaud–Ratti, Véronique"
-
1
Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas
Published in The oncologist (Dayton, Ohio) (01-08-2019)“…Background International guidelines suggest hepatitis C virus (HCV) eradication by direct‐acting antivirals (DAAs) after first‐line immunochemotherapy (I‐CT)…”
Get full text
Journal Article -
2
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Published in The Lancet infectious diseases (01-04-2015)“…Summary Background Patients with cirrhosis resulting from chronic hepatitis C virus (HCV) infection are at risk of life-threatening complications, but…”
Get full text
Journal Article -
3
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Published in Journal of hepatology (01-01-2017)“…Graphical abstract…”
Get full text
Journal Article -
4
Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study
Published in Fundamental & clinical pharmacology (01-04-2018)Get full text
Journal Article -
5
Double-clip traction could be superior to the pocket-creation method with cylindrical cap for colonic ESD: a randomized study in an ex vivo model
Published in Surgical endoscopy (01-03-2021)“…Introduction In Western countries, debates between ESD vs piece-meal EMR as the best treatment for large colorectal adenomas persist regarding the difficulty…”
Get full text
Journal Article -
6
Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
Published in Hepatology (Baltimore, Md.) (01-06-2014)Get full text
Journal Article -
7
Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients
Published in Transplantation (01-10-2016)“…BACKGROUNDThis study investigated the influence of the CYP3A4*22, CYP3A5*3, and ABCB1 exons 12, 21, and 26 polymorphisms in donors and recipients on clinical…”
Get full text
Journal Article -
8
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
Published in BMC gastroenterology (12-09-2023)“…Abstract Background The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult…”
Get full text
Journal Article -
9
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
Published in Clinics and research in hepatology and gastroenterology (01-09-2021)“…•We explored the pathways leading to hepatocellular carcinoma in hepatitis B disease.•The relationships between clinical characteristics and the cancer were…”
Get full text
Journal Article -
10
Sex and Acquired Cofactors Determine Phenotypes of Ferroportin Disease
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2011)“…Background & Aims Ferroportin disease is characterized by iron overload. It has an autosomal-dominant pattern of inheritance and has been associated with…”
Get full text
Journal Article -
11
Anti-hepatitis C virus drugs and kidney
Published in World journal of hepatology (18-11-2016)“…Hepatitis C virus(HCV) mainly targets the liver but can also induce extrahepatic manifestations. The kidney may be impacted via an immune mediated mechanism or…”
Get full text
Journal Article -
12
Sofosbuvir and the risk of kidney dysfunction
Published in Journal of hepatology (01-01-2021)Get full text
Journal Article -
13
BDNF levels and liver stiffness in subjects with alcohol use disorder: Evaluation after alcohol withdrawal
Published in The American journal of drug and alcohol abuse (04-03-2021)“…Background: Brain-derived neurotrophic factor (BDNF) plays a key role in the processes of withdrawal and addiction in alcohol use disorder (AUD), and is also…”
Get full text
Journal Article -
14
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Published in Journal of hepatology (01-09-2013)“…Background & Aims In phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin with boceprevir or telaprevir) seems to be similar…”
Get full text
Journal Article -
15
Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010
Published in Liver international (01-10-2014)“…Background & Aims To determine the characteristics of hepatitis C (HCV)‐infected patients in 2010 and compare this survey with those reported in 1995 and 2001…”
Get full text
Journal Article -
16
Double-pigtail plastic stent is effective as a rescue therapy after obstruction of choledochoduodenostomy using a lumen-apposing metal stent
Published in Endoscopy (01-05-2022)Get more information
Journal Article -
17
Cirrhotic patients and older people
Published in World journal of hepatology (27-09-2019)“…The global population is aging, and so the number of older cirrhotic patients is increasing. Older patients are characterised by a risk of frailty and…”
Get full text
Journal Article -
18
Ribavirin therapeutic drug monitoring: why, when and how?
Published in Fundamental & clinical pharmacology (01-08-2010)“…Recent studies suggest the potential interest of ribavirin therapeutic drug monitoring to improve sustain virological response rate in hepatitis C…”
Get full text
Journal Article -
19
-
20
Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors
Published in Transplantation (01-08-2015)“…One of the main selection criteria of the quality of a liver graft is the degree of steatosis, which will determine the success of the transplantation. The aim…”
Get full text
Journal Article